APJ antagonist-1
APJ antagonist-1 is an apelin receptor (APJ) antagonist. APJ antagonist-1 shows strong β-arrestin inhibition with an IC50 of 3.1 μM. APJ antagonist-1 selectively inhibits APJ-overexpressing cancer cells and suppresses apelin-induced endothelial cell migration. APJ antagonist-1exhibits high metabolic stability. APJ antagonist-1 can used for the studies of ovarian cancer and tumor angiogenesis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C18H15N3O6S2
- Masse moléculaire:433.46
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
APJ antagonist-1 (Compound 21) (1 h) exhibits significantly enhanced metabolic stability than ML221 (HY-103254) (100 % remaining in plasma after 1 h; liver microsomal t1/2 = 5 min)[1].
APJ antagonist-1 (12.5-100 μM, 3 days) shows a greater reduction in the viability of OVCAR8 cells and HT-29 cells[1].
APJ antagonist-1 (30 μM, 8 h) significantly inhibits Apelin (HY-175818)-induced migration in OVCAR3 cells and HUVECs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:OVCAR3 cells and HUVECs
-
Concentration:30 μM
-
Incubation Time:8 h
-
Result:Significantly inhibited apelin-induced migration and the effect was comparable to or even better than ML211.
Chemical Information
-
Masse moléculaire 433.46
-
Formule C18H15N3O6S2
-
SMILES
O=S(C1=CC=C([N+]([O-])=O)C=C1)(OC2=CC(CSC3=NC=CC=N3)=CC=C2OC)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)